Vivos Inc. (OTCMKTS:RDGL – Get Free Report) was the target of a large growth in short interest in March. As of March 31st, there was short interest totalling 104,000 shares, a growth of 303.1% from the March 15th total of 25,800 shares. Based on an average daily volume of 634,500 shares, the short-interest ratio is currently 0.2 days.
Vivos Stock Performance
OTCMKTS RDGL opened at $0.08 on Thursday. The stock’s 50 day moving average price is $0.06 and its two-hundred day moving average price is $0.06. Vivos has a 52 week low of $0.04 and a 52 week high of $0.12.
Vivos (OTCMKTS:RDGL – Get Free Report) last released its earnings results on Monday, March 18th. The company reported ($0.01) EPS for the quarter.
About Vivos
Vivos Inc, a radiation oncology medical device company, develops brachytherapy devices for the treatment of non-resectable tumors in the United States and internationally. It develops yttrium-90 based RadioGel device, an injectable particle-gel for brachytherapy radiation treatment of cancerous tumors in people and animals; and IsoPet for the treatment of solid tumors in animals.
Featured Stories
- Five stocks we like better than Vivos
- What is Short Interest? How to Use It
- Heat Alert: Micron Just Got Named A Must-Own Stock for Q2
- The 3 Best Blue-Chip Stocks to Buy Now
- WD-40 Company Greases the Wheels of Growth and Profits
- What is a Stock Market Index and How Do You Use Them?
- How to Protect your Portfolio Against a Rising VIX
Receive News & Ratings for Vivos Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vivos and related companies with MarketBeat.com's FREE daily email newsletter.
